Keep updated
Get in touch
Canonical ID: ir-br-co-6255e6de5391ed201369804ec44016faa2a28905 · Entity type: Company (reference)
| Property | Value | Lang | Source dataset | Source ID | First seen | ||
|---|---|---|---|---|---|---|---|
Company:country | es | ir_uani_business_registry | ir-br-co-6255e6de5391ed201369804ec44016faa2a28905 | ||||
Company:id | 36ed29e04ec5aec774d99f4e7311b51eff3e1902 | ir_uani_business_registry | ir-br-co-6255e6de5391ed201369804ec44016faa2a28905 | ||||
Company:name | Chemo Group | ir_uani_business_registry | ir-br-co-6255e6de5391ed201369804ec44016faa2a28905 | ||||
Company:notes | "Iranian media reported in March 2016 that Barakat Pharmed had signed a $15 million deal for Spain-based pharmaceutical company Chemo Group to buy a 65 percent stake in a Barakat subsidiary. A 2016 Barakat annual report states that 65 percent of shares of Ati Pharmed, previously owned by Barakat and Alborz Investment Group, a Barakat subsidiary, were transferred to Chemo. A person familiar with Ati Pharmed affairs confirmed the transfer. Chemo officials did not respond to requests for comment." (Reuters, "Post-Sanctions Deals with Iranian Firms Linked to Khamenei," 1/19/2017). (http://www.dailymail.co.uk/wires/reuters/article-4136746/Post-sanctions-deals-Iranian-firms-linked-Khamenei.html) | ir_uani_business_registry | ir-br-co-6255e6de5391ed201369804ec44016faa2a28905 | ||||
Company:sector | Pharmaceuticals | ir_uani_business_registry | ir-br-co-6255e6de5391ed201369804ec44016faa2a28905 | ||||
Company:sourceUrl | https://www.unitedagainstnucleariran.com/index.php/company/chemo-group | ir_uani_business_registry | ir-br-co-6255e6de5391ed201369804ec44016faa2a28905 | ||||
Company:topics | export.risk | ir_uani_business_registry | ir-br-co-6255e6de5391ed201369804ec44016faa2a28905 | ||||
Company:website | http://www.chemogroup.com/ | ir_uani_business_registry | ir-br-co-6255e6de5391ed201369804ec44016faa2a28905 | ||||